The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 1

Donor characteristics.

	Sevoflurane group	Control group	Mann-Whitney, 𝑃 value
Donor age, y	32 (24–46)	39 (25–46)	0,515
Weight, kg	75 (63,5–80)	75,5 (70–85)	0,596
BMI, kg/m^2	24,2 (22,8–25,9)	24,8 (21,9–26,8)	0,744
Cold ischemia time, min	455 (365–565)	465 (400–585)	0,329
Warm ischemia time, min	62,5 (60–70)	67,5 (60–70)	0,623
Percentage of macrovesicular steatosis, %	15 (0–20)	10 (0–20)	0,922
DRI score	1,19 (1,03–1,25)	1,23 (1,11–1,38)	0,186

Data are as median (interquartile range). BMI: body mass index, DRI: donor risk injury.